Search results
4 days ago · “This kind of behavior has been pointed out to the FDA time and time again by people like me for the last 10 years,” said Dinesh Thakur, a former pharmaceutical industry executive who became a whistleblower for the U.S. government. In 2013, his work led to a $500 million settlement with Indian drugmaker Ranbaxy for falsifying generic drug data.
2 days ago · “This kind of behavior has been pointed out to the FDA time and time again by people like me for the last 10 years,” said Dinesh Thakur, a former pharmaceutical industry executive who became a whistleblower for the U.S. government. In 2013, his work led to a $500 million settlement with Indian drugmaker Ranbaxy for falsifying generic drug data.
5 days ago · “This kind of behavior has been pointed out to the FDA time and time again by people like me for the last 10 years,” said Dinesh Thakur, a former pharmaceutical industry executive who became a ...
5 days ago · “This kind of behavior has been pointed out to the FDA time and time again by people like me for the last 10 years,” said Dinesh Thakur, a former pharmaceutical industry executive who became a ...
4 days ago · Dinesh Thakur, a fascinated by technology since childhood, has mastered programming through dedication. Whether working solo or in a team, he thrives on challenges, crafting innovative solutions. Join 10k developers and get weekly updates with Requestly's newsletter.
20 hours ago · Dinesh S. Thakur is the co-author of ‘The Truth Pill: The Myth of Drug Regulation in India’ (2022). Prashant Reddy T. is the co-author of ‘The Truth Pill: The Myth of Drug Regulation in ...
2 days ago · Share your videos with friends, family, and the world